Lenacapavir, HIV Injectable Drug Offers Pregnant, Lactating Mothers 100 Percent Protection – Study
Lenacapavir, injectable HIV prevention drug, has been found to provide 100 percent protection against HIV infection among pregnant and breastfeeding women using it as pre-exposure prophylaxis (PrEP). This is according to sub-study of the landmark clinical trial evaluating the safety and efficacy